β-D-Glucan testing is important for diagnosis of invasive fungal infections

Journal of Clinical Microbiology

Volumn 51, Issue 11, 2013, Pages 3478-3483

  Theel, Elitza S ^a   Doern, Christopher D ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,3 GLUCAN; BETA LACTAM ANTIBIOTIC; ECHINOCANDIN; FUNGAL POLYSACCHARIDE; FUNGUS ANTIGEN; GALACTOMANNAN; HISTOPLASMA ANTIGEN; IMMUNOGLOBULIN; UNCLASSIFIED DRUG;

ANTIGEN DETECTION; ARTICLE; ASPERGILLUS; BLEEDING; BLOOD CULTURE; CANDIDA; CARBOHYDRATE ANALYSIS; CEREBROSPINAL FLUID EXAMINATION; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; CROSS REACTION; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; DIAGNOSTIC VALUE; ENZYME IMMUNOASSAY; FALSE POSITIVE RESULT; FILTER; FUNGUS CULTURE; GRAFT RECIPIENT; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMODIALYSIS; HIGH RISK PATIENT; HISTOPATHOLOGY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; LABORATORY TEST; LUNG LAVAGE; LUNG MYCOSIS; MORBIDITY; MORTALITY; NEUTROPENIA; NONHUMAN; PATIENT SAFETY; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PREDICTIVE VALUE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SENSITIVITY AND SPECIFICITY; SEROLOGY; SYSTEMIC MYCOSIS; THROMBOCYTOPENIA; TISSUE CULTURE; TREATMENT FAILURE; TREATMENT OUTCOME;

ANTIGENS, FUNGAL; DIAGNOSTIC ERRORS; GLUCANS; HUMANS; IMMUNOCOMPROMISED HOST; MYCOSES;

EID: 84886494497     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.01737-13     Document Type: Article

References (18)

1. Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, Ketchum PA, Wingard J, Schiff R, Tamura H, Finkelman MARex JH. 2005. Multicenter clinical evaluation of the (13) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin. Infect. Dis. 41:654-659.
2. Lu Y, Chen YQ, Guo YL, Qin SM, Wu C, Wang K. 2011. Diagnosis of invasive fungal disease using serum (13)-beta-D-glucan: a bivariate meta-analysis. Intern. Med. 50:2783-2791.
3. Koo S, Bryar JM, Page JH, Baden LR, Marty FM. 2009. Diagnostic performance of the (13)-beta-D-glucan assay for invasive fungal disease. Clin. Infect. Dis. 49:1650-1659.
4. Hanson KE, Pfeiffer CD, Lease ED, Balch AH, Zaas AK, Perfect JR, Alexander BD. 2012.-D-Glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study. PLoS One 7(8):e42282. doi:10.1371/journal.pone.0042282.
5. Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, Ketchum PA, Finkelman MA, Rex JH, Ostrosky-Zeichner L. 2004.-D-Glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin. Infect. Dis. 39:199-205.
6. Onishi A, Sugiyama D, Kogata Y, Saegusa J, Sugimoto T, Kawano S, Morinobu A, Nishimura K, Kumagai S. 2012. Diagnostic accuracy of serum 1,3-beta-D-glucan for Pneumocystis jiroveci [sic] pneumonia, invasive candidiasis, and invasive aspergillosis: systematic review and metaanalysis. J. Clin. Microbiol. 50:7-15.
7. Hachem RY, Kontoyiannis DP, Chemaly RF, Jiang Y, Reitzel R, Raad I. 2009. Utility of galactomannan enzyme immunoassay and (1,3) beta-Dglucan in diagnosis of invasive fungal infections: low sensitivity for Aspergillus fumigatus infection in hematologic malignancy patients. J. Clin. Microbiol. 47:129-133.
8. Yoshida K, Shoji H, Takuma T, Niki Y. 2011. Clinical viability of Fungitell, a new (13)-D-glucan measurement kit, for diagnosis of invasive fungal infection, and comparison with other kits available in Japan. J. Infect. Chemother. 17:473-477.
9. Obayashi T, Negishi K, Suzuki T, Funata N. 2008. Reappraisal of the serum (13)-beta-D-glucan assay for the diagnosis of invasive fungal infections- a study based on autopsy cases from 6 years. Clin. Infect. Dis. 46:1864-1870.
10. De Vlieger G, Lagrou K, Maertens J, Verbeken E, Meersseman W, Van Wijngaerden E. 2011.-D-Glucan detection as a diagnostic test for invasive aspergillosis in immunocompromised critically ill patients with symptoms of respiratory infection: an autopsy-based study. J. Clin. Microbiol. 49:3783-3787.
11. Metan G, Agkus C, Nedret Koc A, Elmali F, Finkelman MA. 2012. Does ampicillin-sulbactam cause false positivity of (1,3)-beta-D-glucan assay? A prospective evaluation of 15 patients without invasive fungal infections. Mycoses 55:366-371.
12. Marty FM, Koo S. 2009. Role of (13)-beta-D-glucan in the diagnosis of invasive aspergillosis. Med. Mycol. 47(Suppl 1):S233-S240.
13. Marty FM, Lowry CM, Lempitski SJ, Kubiak DW, Finkelman MA, Baden LR. 2006. Reactivity of (13)-beta-D-glucan assay with commonly used intravenous antimicrobials. Antimicrob. Agents Chemother. 50:3450-3453.
14. Pfaller MA. 2012. Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment. Am. J. Med. 125(Suppl 1):S3-S13.
15. Tashiro M, Izumikawa K, Hirano K, Ide S, Mihara T, Hosogaya N, Takazono T, Morinaga Y, Nakamura S, Kurihara S, Imamura Y, Miyazaki T, Nishino T, Tsukamoto M, Kakeya H, Yamamoto Y, Yanagihara K, Yasuoka A, Tashiro T, Kohno S. 2012. Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus. Antimicrob. Agents Chemother. 56:4870-4875.
16. Racil Z, Kocmanova I, Lengerova M, Weinbergerova B, Buresova L, Toskova M, Winterova J, Timilsina S, Rodriguez I, Mayer J. 2010. Difficulties in using 1,3-D-glucan as the screening test for the early diagnosis of invasive fungal infections in patients with haematological malignancies- high frequency of false-positive results and their analysis. J. Med. Microbiol. 59(Part 9):1016-1022.
17. Senn L, Robinson JO, Schmidt S, Knaup M, Asahi N, Satomura S, Matsuura S, Duvoisin B, Bille J, Calandra T, Marchetti O. 2008. ,3-DGlucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin. Infect. Dis. 46:878-885.
18. Bellanger A, Grenouillet F, Henon T, Skana F, Legrand F, Deconinck E, Millon L. 2011. Retrospective assessment of-D-(1,3)-glucan for presumptive diagnosis of fungal infections. APMIS 119:280-286.